Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study

Yoshiyasu Umeda(Kawasaki Medical School), Shusuke Yoshikawa(Shizuoka Cancer Center), Yukiko Kiniwa(Shinshu University), Takeo Maekawa(Jichi Medical University), Osamu Yamasaki(Okayama University), Taiki Isei(Osaka International Cancer Institute), Shigeto Matsushita(National Hospital Organization), Motoo Nomura(Kyoto University), Yasuo Nakai(Mie University), Satoshi Fukushima(Kumamoto University), Shintaro Saito(Gunma University), Tatsuya Takenouchi(Niigata Cancer Center Hospital), Ryo Tanaka(Kawasaki Medical School), Hiroshi Kato(Nagoya City University), Atsushi Otsuka(Kyoto University), Taisuke Matsuya(Asahikawa Medical University), Natsuki Baba(University of Fukui), Kotaro Nagase(Saga University), Takashi Inozume(Chiba University), T Onuma(University of Yamanashi), Yutaka Kuwatsuka(Nagasaki University), Noriki Fujimoto(Shiga University of Medical Science), Takahide Kaneko(Juntendo University Urayasu Hospital), Masazumi Onishi(Iwate Medical University), Kenjiro Namikawa, Naoya Yamazaki, Yasuhiro Nakamura(Saitama International Medical Center)
European Journal of Cancer
September 23, 2021
Cited by 41

Abstract


Related Papers

No related papers found

Powered by citation graph analysis